Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

10.90
Delayed Data
As of May 01
 +0.24 / +2.25%
Today’s Change
10.33
Today|||52-Week Range
18.48
-22.97%
Year-to-Date

Stock Price Forecast

The 11 analysts offering 12-month price forecasts for Keryx Biopharmaceuticals Inc have a median target of 25.00, with a high estimate of 32.00 and a low estimate of 17.00. The median estimate represents a +129.36% increase from the last price of 10.90.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Keryx Biopharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.28
Sales
$2.1M
Reporting Date
May 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 36.87%
 
 
 
 
 
 
Growthannually 28.33%
 
 
 
 
 
 

Sales

Growthquarterly 268.96%
 
 
 
 
 
 
Growthannually 283.54%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account